Science Explorer Interactive view Map
Company · Seattle · United States

Aptevo Therapeutics (United states)

aptevotherapeutics.comROR OpenAlex
Research works
66
◆ 2% vs 2013–17
Citations
1.2k
18.4 per fractional work
Top-10% rate
0.5%
record average 16.5%
Open access
30%
world 28%

Not ranked overall: Aptevo Therapeutics (United states) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 5.24× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 15.37× its world share, 1 worksImmunology and Micro…Neuroscience: 1.31× its world share, 0 worksNeuroscienceChemistry: 1.69× its world share, 0 worksChemistryEngineering: 0.35× its world share, 0 worksEngineeringEnvironmental Science: 0.62× its world share, 0 worksEnvironmental ScienceMedicine: 2.00× its world share, 2 worksMedicineNursing: 2.71× its world share, 0 worksNursingDecision Sciences: 0.92× its world share, 0 worksDecision SciencesPsychology: 0.05× its world share, 0 worksPsychologySocial Sciences: 0.21× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 15.4×. Every wedge is a field page.

Who are the top researchers at Aptevo Therapeutics (United states)?

Ranked on the composite score, April Slee lead among researchers whose main affiliation is Aptevo Therapeutics (United states).

  1. 1 April Slee United States · #584,886 worldwide 64 citations · 34 works
All ranked researchers at Aptevo Therapeutics (United states)

Which keywords describe research at Aptevo Therapeutics (United states)?

By fractional works in all years, weighted toward what it does more of than the world: Cancer Immunotherapy, Immunotherapy, Lymphoma, Tumor Regression, CAR T Cells, Chimeric Antigen Receptor, Clinical Trials and Immunity.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Cancer Immunotherapy7▲ 76×2 topics
  2. Immunotherapy6▲ 14×6 topics
  3. Lymphoma5▲ 47×2 topics
  4. Tumor Regression5▲ 80×2 topics
  5. CAR T Cells4▲ 148×1 topic
  6. Chimeric Antigen Receptor4▲ 148×1 topic
  7. Inflammation4▲ 2.4×16 topics
  8. Clinical Trials3▲ 8.2×8 topics
  9. Immunity3▲ 13×3 topics
  10. Antigen Presentation3▲ 42×2 topics
  11. Dendritic Cells3▲ 36×2 topics
  12. Glycosylation3▲ 19×2 topics
  13. Monoclonal Antibodies3▲ 29×2 topics
  14. Tumor Antigen3▲ 51×1 topic
  15. Vaccine Adjuvants3▲ 51×1 topic
  16. Cardiovascular Disease3▲ 3.6×14 topics
  17. Diabetes3▲ 7.5×9 topics
  18. Fc Receptors3▲ 40×1 topic
  19. Therapeutic Antibodies3▲ 31×1 topic
  20. Glycemic Control2▲ 26×3 topics
  21. Clinical Guidelines2▲ 11×4 topics
  22. Obesity2▲ 4.1×8 topics
  23. Genetics2▲ 3.8×5 topics
  24. Heart Failure2▲ 6.2×6 topics
  25. Prevalence2▲ 7.2×3 topics
  26. Design2▲ 23×2 topics
  27. Insulin Therapy2▲ 24×2 topics
  28. Neurobiology2▲ 8.1×4 topics
  29. Genetic Variants2▲ 11×3 topics
  30. Type 2 Diabetes2▲ 13×3 topics
  31. Cardiovascular Disease Prevention2▲ 28×2 topics
  32. Cardiovascular Risk2▲ 6.5×5 topics
  33. Gene Therapy2▲ 8.7×4 topics
  34. Cardiovascular Outcomes1▲ 50×1 topic
  35. Cholesterol1▲ 12×2 topics
  36. Glucose Control1▲ 50×1 topic
  37. Neuroimaging1▲ 7.4×2 topics
  38. Prostate Cancer1▲ 14×2 topics
  39. Targeted Therapy1▲ 9.8×4 topics
  40. Treatment Guidelines1▲ 10×3 topics

Which research topics does Aptevo Therapeutics (United states) publish most on?

By volume in 2022–2025: CAR-T cell therapy research, Monoclonal and Polyclonal Antibodies Research, Cancer Immunotherapy and Biomarkers and Toxin Mechanisms and Immunotoxins.

CAR-T cell therapy resea…0CAR-T cell therapy research: 0 fractional worksMonoclonal and Polyclona…0Monoclonal and Polyclonal Antibodies Research: 0 fractional worksCancer Immunotherapy and Biomarkers: 0 fractional worksToxin Mechanisms and Immunotoxins: 0 fractional worksEstrogen and related hor…0Estrogen and related hormone effects: 0 fractional worksCancer Genomics and Diagnostics: 0 fractional worksCancer Cells and Metastasis: 0 fractional worksEpigenetics and DNA Meth…0Epigenetics and DNA Methylation: 0 fractional worksImmune Cell Function and Interaction: 0 fractional worksMicrotubule and mitosis dynamics: 0 fractional works
OncologyRadiology, Nuclear Medicine and ImagingImmunologyGenetics3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 CAR-T cell therapy research Oncology 0 works
  2. 2 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
  3. 3 Cancer Immunotherapy and Biomarkers Oncology 0 works
  4. 4 Toxin Mechanisms and Immunotoxins Immunology 0 works
  5. 5 Estrogen and related hormone effects Genetics 0 works
  6. 6 Cancer Genomics and Diagnostics Cancer Research 0 works
  7. 7 Cancer Cells and Metastasis Oncology 0 works
  8. 8 Epigenetics and DNA Methylation Molecular Biology 0 works
  9. 9 Immune Cell Function and Interaction Immunology 0 works
  10. 10 Microtubule and mitosis dynamics Cell Biology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available30.2%not open69.8%

World: 28% of research is openly available.

with international co-authors16.4%domestic only83.6%

World: 19% is written across borders.

How has Aptevo Therapeutics (United states)'s research output changed?

Output in 2018–2022 was 2% lower than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Seattle

All research institutions in Seattle

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.